← Leaderboards
Gustavo Nino
Children'S Research Institute
$5,538,547
Attributed
$8,444,646
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.1M · FY2017–25$5M$3.8M$2.5M$1.3M$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,444,646 · 6
By mechanism
R01$5,603,988 · 2
R42$1,678,216 · 1
R21$495,305 · 1
R56$442,325 · 1
R41$224,812 · 1
Top collaborators
- Jyoti K Jaiswal4 shared
- Andinet Asmamaw Enquobahrie3 shared
- Marius George Linguraru3 shared
Most similar at Children'S Research Institute
Same institution · by research overlap
- Kevin Robert Cleary$15,677,966
Others in their field
Other Emerging Leaders on “Exposure To”
- Chanza Baytop · Westat, Inc.$271,217,917
- Yunda Huang · Fred Hutchinson Cancer Center$65,418,952
- Prasant Mohapatra · University Of California At Davis$51,108,355
- Ellen Gould Chadwick · Harvard University D/B/A Harvard School Of Public Health$25,473,113
- Leonard Freedman · Leidos Biomedical Research, Inc.$20,851,347
- Kristin Aillon · Midwest Research Institute$18,958,174
Research focus
Exposure ToHigh RiskHospitalizationNoseViralMolecularSeveritiesResponseEpithelial CellsAirway EpitheliumImmune ResponseVirusSignal TransductionMediatingIn VivoBaseAdultRespiratory Syncytial VirusLifeExhibitsChildRespiratory Syncytial Virus InfectionsGenetic TranscriptionMortality
Grant awards (14)
Molecular mechanism of dysregulated airway antiviral responses in children with Trisomy 21$571,961
R01 · FY2025 · HL · contact PI
Molecular mechanism of dysregulated airway antiviral responses in children with Trisomy 21$569,440
R01 · FY2024 · HL · contact PI
Imaging biomarkers of severe respiratory infections in premature infants Phase II$826,115
R42 · FY2022 · HL
THE HUMAN INFANT AIRWAY EPITHELIUM AND RECURRENT WHEEZING AFTER RV AND RSV INFECTION$582,290
R01 · FY2022 · HL · contact PI
Molecular mechanism of dysregulated airway antiviral responses in children with Trisomy 21$1,643,687
R01 · FY2021 · HL · contact PI
Imaging biomarkers of severe respiratory infections in premature infants Phase II$852,101
R42 · FY2021 · HL
THE HUMAN INFANT AIRWAY EPITHELIUM AND RECURRENT WHEEZING AFTER RV AND RSV INFECTION$582,290
R01 · FY2021 · HL · contact PI
THE HUMAN INFANT AIRWAY EPITHELIUM AND RECURRENT WHEEZING AFTER RV AND RSV INFECTION$582,290
R01 · FY2020 · HL · contact PI
IFN responses and SARS-CoV-2 Receptor ACE2 Expression in the airway epithelium of young children with Down Syndrome$489,740
R01 · FY2020 · HL · contact PI
THE HUMAN INFANT AIRWAY EPITHELIUM AND RECURRENT WHEEZING AFTER RV AND RSV INFECTION$582,290
R01 · FY2019 · HL · contact PI
TSLP responses in the human infant airway epithelium and recurrent wheezing after RV and RSV Infection$442,325
R56 · FY2018 · HL · contact PI
Exosomal miR-155 regulates airway epithelial immune responses in infants with rhinovirus infection$261,022
R21 · FY2018 · AI · contact PI
Imaging Biomarkers of Severe Respiratory Infections in Premature Infants$224,812
R41 · FY2018 · HL
Exosomal miR-155 regulates airway epithelial immune responses in infants with rhinovirus infection$234,283
R21 · FY2017 · AI · contact PI